{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:15Z","timestamp":1790683875761,"version":"4.1.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,13]]},"DOI":"10.7759\/cureus.75644","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T13:48:35Z","timestamp":1734097715000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Primary Aldosteronism Masquerading as Bartter and Gitelman Syndromes"],"prefix":"10.7759","author":[{"given":"Narasingolu  M","family":"Hasini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul K","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Quaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4061\/2011\/162804","article-title":"Changes in the perceived epidemiology of primary hyperaldosteronism","volume":"4","author":"Fagugli RM","year":"2011","unstructured":"Fagugli RM, Taglioni C. Changes in the perceived epidemiology of primary hyperaldosteronism. Int J Hypertens. 2011, 4:804. 10.4061\/2011\/162804","journal-title":"Int J Hypertens"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12831","article-title":"Diagnosis and treatment of primary aldosteronism: practical clinical perspectives","volume":"285","author":"Young WF Jr","year":"2019","unstructured":"Young WF Jr. Diagnosis and treatment of primary aldosteronism: practical clinical perspectives. J Intern Med. 2019, 285:126-48. 10.1111\/joim.12831","journal-title":"J Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero P","year":"2011","unstructured":"Mulatero P, Tizzani D, Viola A, et al.. Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms). Hypertension. 2011, 58:797-803. 10.1161\/HYPERTENSIONAHA.111.175083","journal-title":"Hypertension"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11150","article-title":"Saga of familial hyperaldosteronism: yet a new channel","volume":"71","author":"Lenzini L","year":"2018","unstructured":"Lenzini L, Prisco S, Caroccia B, Rossi GP. Saga of familial hyperaldosteronism: yet a new channel. Hypertension. 2018, 71:1010-4. 10.1161\/HYPERTENSIONAHA.118.11150","journal-title":"Hypertension"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1564166","article-title":"An update on familial hyperaldosteronism","volume":"47","author":"Korah HE","year":"2015","unstructured":"Korah HE, Scholl UI. An update on familial hyperaldosteronism. Horm Metab Res. 2015, 47:941-6. 10.1055\/s-0035-1564166","journal-title":"Horm Metab Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14063","article-title":"Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit","volume":"75","author":"Burrello J","year":"2020","unstructured":"Burrello J, Monticone S, Losano I, et al.. Prevalence of hypokalemia and primary aldosteronism in 5100 patients referred to a tertiary hypertension unit. Hypertension. 2020, 75:1025-33. 10.1161\/HYPERTENSIONAHA.119.14063","journal-title":"Hypertension"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1410279","article-title":"Aldosterone-producing adenoma without hypertension: a report of two cases","volume":"141","author":"Vantyghem MC","year":"1999","unstructured":"Vantyghem MC, Ronci N, Provost F, Ghulam A, Lefebvre J, Jeunemaitre X, Tabarin A. Aldosterone-producing adenoma without hypertension: a report of two cases. Eur J Endocrinol. 1999, 141:279-85. 10.1530\/eje.0.1410279","journal-title":"Eur J Endocrinol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba K","year":"2020","unstructured":"Nanba K, Blinder AR, Rege J, et al.. Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma. Hypertension. 2020, 75:645-9. 10.1161\/HYPERTENSIONAHA.119.14349","journal-title":"Hypertension"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism - a multidimensional syndrome","volume":"18","author":"Turcu AF","year":"2022","unstructured":"Turcu AF, Yang J, Vaidya A. Primary aldosteronism - a multidimensional syndrome. Nat Rev Endocrinol. 2022, 18:665-82. 10.1038\/s41574-022-00730-2","journal-title":"Nat Rev Endocrinol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-11-199412010-00010","article-title":"Diagnosis and treatment of primary hyperaldosteronism","volume":"121","author":"Blumenfeld JD","year":"1994","unstructured":"Blumenfeld JD, Sealey JE, Schlussel Y, et al.. Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med. 1994, 121:877-85. 10.7326\/0003-4819-121-11-199412010-00010","journal-title":"Ann Intern Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil G","year":"2016","unstructured":"Daniil G, Fernandes-Rosa FL, Chemin J, et al.. CACNA1H mutations are associated with different forms of primary aldosteronism. EBioMedicine. 2016, 13:225-36. 10.1016\/j.ebiom.2016.10.002","journal-title":"EBioMedicine"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1170","article-title":"CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by mibefradil","volume":"157","author":"Reimer EN","year":"2016","unstructured":"Reimer EN, Walenda G, Seidel E, Scholl UI. CACNA1H(M1549V) mutant calcium channel causes autonomous aldosterone production in HAC15 cells and is inhibited by mibefradil. Endocrinology. 2016, 157:3016-22. 10.1210\/en.2016-1170","journal-title":"Endocrinology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.1.5794.220","article-title":"Hyperaldosteronism from adrenal carcinoma","volume":"1","author":"Brooks RV","year":"1972","unstructured":"Brooks RV, Felix-Davies D, Lee MR, Robertson PW. Hyperaldosteronism from adrenal carcinoma. Br Med J. 1972, 1:220-1. 10.1136\/bmj.1.5794.220","journal-title":"Br Med J"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2010.166","article-title":"Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects","volume":"34","author":"Ito Y","year":"2011","unstructured":"Ito Y, Takeda R, Karashima S, Yamamoto Y, Yoneda T, Takeda Y. Prevalence of primary aldosteronism among prehypertensive and stage 1 hypertensive subjects. Hypertens Res. 2011, 34:98-102. 10.1038\/hr.2010.166","journal-title":"Hypertens Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020826","article-title":"Normotensive hypokalemic primary hyperaldosteronism mimicking clinical features of anorexia nervosa in a young patient: a case report","volume":"99","author":"Huang YC","year":"2020","unstructured":"Huang YC, Tsai MH, Fang YW, Tu ML. Normotensive hypokalemic primary hyperaldosteronism mimicking clinical features of anorexia nervosa in a young patient: a case report. Medicine (Baltimore). 2020, 99:e20826. 10.1097\/MD.0000000000020826","journal-title":"Medicine (Baltimore)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.6.6651","article-title":"Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance","volume":"85","author":"Stowasser M","year":"2000","unstructured":"Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD. Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J Clin Endocrinol Metab. 2000, 85:2160-6. 10.1210\/jcem.85.6.6651","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.107.091785","article-title":"Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring","volume":"50","author":"Ojeda NB","year":"2007","unstructured":"Ojeda NB, Grigore D, Robertson EB, Alexander BT. Estrogen protects against increased blood pressure in postpubertal female growth restricted offspring. Hypertension. 2007, 50:679-85. 10.1161\/HYPERTENSIONAHA.107.091785","journal-title":"Hypertension"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/14703203211003780","article-title":"Normotensive presentation in primary aldosteronism: a report of two cases","volume":"22","author":"Jia M","year":"2021","unstructured":"Jia M, Yu H, Liu Z, He M, Zhong S, Xu X, Song X. Normotensive presentation in primary aldosteronism: a report of two cases. J Renin Angiotensin Aldosterone Syst. 2021, 22:80. 10.1177\/14703203211003780","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-019-0934-y","article-title":"Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels","volume":"21","author":"Stowasser M","year":"2019","unstructured":"Stowasser M, Wolley M, Wu A, Gordon RD, Schewe J, St\u00f6lting G, Scholl UI. Pathogenesis of familial hyperaldosteronism type II: new concepts involving anion channels. Curr Hypertens Rep. 2019, 21:31. 10.1007\/s11906-019-0934-y","journal-title":"Curr Hypertens Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/321074-a-case-of-primary-aldosteronism-masquerading-as-bartter-and-gitelman-syndromes","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T13:48:36Z","timestamp":1734097716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/321074-a-case-of-primary-aldosteronism-masquerading-as-bartter-and-gitelman-syndromes"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.75644","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}